Related references
Note: Only part of the references are listed.Cytoplasmic MTAP expression loss detected by immunohistochemistry correlates with 9p21 homozygous deletion detected by FISH in pleural effusion cytology of mesothelioma
Makoto Hamasaki et al.
HISTOPATHOLOGY (2019)
Guidelines for Pathologic Diagnosis of Malignant Mesothelioma 2017 Update of the Consensus Statement From the International Mesothelioma Interest Group
Aliya Noor Husain et al.
ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE (2018)
Treatment of Malignant Pleural Mesothelioma: American Society of Clinical Oncology Clinical Practice Guideline
Hedy L. Kindler et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
British Thoracic Society Guideline for the investigation and management of malignant pleural mesothelioma
Ian Woolhouse et al.
THORAX (2018)
Utility of Methylthioadenosine Phosphorylase Compared With BAP1 Immunohistochemistry, and CDKN2A and NF2 Fluorescence In Situ Hybridization in Separating Reactive Mesothelial Proliferations From Epithelioid Malignant Mesotheliomas
Kyra B. Berg et al.
ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE (2018)
A combination of MTAP and BAP1 immunohistochemistry in pleural effusion cytology for the diagnosis of mesothelioma
Yoshiaki Kinoshita et al.
CANCER CYTOPATHOLOGY (2018)
Immunohistochemical detection of MTAP and BAP1 protein loss for mesothelioma diagnosis: Comparison with 9p21 FISH and BAP1 immunohistochemistry
Tomoyuki Hida et al.
LUNG CANCER (2017)
HEG1 is a novel mucin-like membrane protein that serves as a diagnostic and therapeutic target for malignant mesothelioma
Shoutaro Tsuji et al.
SCIENTIFIC REPORTS (2017)
Usefulness of p16/CDKN2A fluorescence in situ hybridization and BAP1 immunohistochemistry for the diagnosis of biphasic mesothelioma
Di Wu et al.
ANNALS OF DIAGNOSTIC PATHOLOGY (2017)
Cytologic Differential Diagnosis of Malignant Mesothelioma and Reactive Mesothelial Cells With FISH Analysis of p16
Kenzo Hiroshima et al.
DIAGNOSTIC CYTOPATHOLOGY (2016)
Low homozygous/high heterozygous deletion status by p16 FISH correlates with a better prognostic group than high homozygous deletion status in malignant pleural mesothelioma
Makoto Hamasaki et al.
LUNG CANCER (2016)
Guidelines for the Cytopathologic Diagnosis of Epithelioid and Mixed-Type Malignant Mesothelioma
Anders Hjerpe et al.
ACTA CYTOLOGICA (2015)
Loss of expression of BAP1 is a useful adjunct, which strongly supports the diagnosis of mesothelioma in effusion cytology
Juliana Andrici et al.
MODERN PATHOLOGY (2015)
BAP1 (BRCA1-associated protein 1) is a highly specific marker for differentiating mesothelioma from reactive mesothelial proliferations
Marta Cigognetti et al.
MODERN PATHOLOGY (2015)
Diagnostic Usefulness of p16/CDKN2A FISH in Distinguishing Between Sarcomatoid Mesothelioma and Fibrous Pleuritis
Di Wu et al.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2013)
Distinguishing benign from malignant mesothelial cells in effusions by Glut-1, EMA, and Desmin expression: An evidence-based approach
Michael Kuperman et al.
DIAGNOSTIC CYTOPATHOLOGY (2013)
Challenges and controversies in the diagnosis of mesothelioma: Part 1. Cytology-only diagnosis, biopsies, immunohistochemistry, discrimination between mesothelioma and reactive mesothelial hyperplasia, and biomarkers
Douglas W. Henderson et al.
JOURNAL OF CLINICAL PATHOLOGY (2013)
Usefulness of Claudin 4 in the Cytological Diagnosis of Serosal Effusions
Silvia Lonardi et al.
DIAGNOSTIC CYTOPATHOLOGY (2011)
The Use of Immunohistochemistry to Distinguish Reactive Mesothelial Cells From Malignant Mesothelioma in Cytologic Effusions
Farnaz Hasteh et al.
CANCER CYTOPATHOLOGY (2010)
Fluorescence In Situ Hybridization in the Definitive Diagnosis of Malignant Mesothelioma in Effusion Cytology
Spasenija Savic et al.
CHEST (2010)
Response to: Pancreatic intraductal lesions with possible relationship with gastric type intraductal papillary mucinous neoplasm: pyloric gland-type intraductal tubular adenoma and intraductal oncocytic papillary neoplasm
Hiromi Tsukiji et al.
HISTOPATHOLOGY (2010)
Immunocytochemistry of CD146 is useful to discriminate between malignant pleural mesothelioma and reactive mesothelium
Ayuko Sato et al.
MODERN PATHOLOGY (2010)
Regulation of cardiovascular development and integrity by the heart of glass-cerebral cavernous malformation protein pathway
Benjamin Kleaveland et al.
NATURE MEDICINE (2009)
9p21 deletion in the diagnosis of malignant mesothelioma in serous effusions additional to immunocytochemistry, DNA-ICM, and AgNOR analysis
Fabiana Botelho de Miranda Onofre et al.
CANCER CYTOPATHOLOGY (2008)
Utility of anti-L523S antibody in the diagnosis of benign and malignant serous effusions
Krisztina Z. Hanley et al.
CANCER CYTOPATHOLOGY (2008)
Claudin 4 identifies a wide spectrum of epithelial neoplasms and represents a very useful marker for carcinoma versus mesothelioma diagnosis in pleural and peritoneal biopsies and effusions
Fabio Facchetti et al.
VIRCHOWS ARCHIV (2007)
Immunohistochemical detection of GLUT-1 can discriminate between reactive mesothelium and malignant mesothelioma
Yasufumi Kato et al.
MODERN PATHOLOGY (2007)
The diagnostic utility of D2-40 for malignant mesothelioma versus pulmonary carcinoma with pleural involvement
Reda S. Saad et al.
DIAGNOSTIC CYTOPATHOLOGY (2006)
Sensitivity and specificity of immunohistochemical antibodies used to distinguish between benign and malignant pleural disease: a systematic review of published reports
J. King et al.
HISTOPATHOLOGY (2006)
Claudins in differential diagnosis between mesothelioma and metastatic adenocarcinoma of the pleura
Y Soini et al.
JOURNAL OF CLINICAL PATHOLOGY (2006)
The use of CDKN2A deletion as a diagnostic marker for malignant mesothelioma in body cavity effusions
PB Illei et al.
CANCER CYTOPATHOLOGY (2003)
Share Paper
